Jiangsu, China

Xiaodong Chen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Nanjing Hepo Pharmaceutical Co., Ltd. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaodong Chen. Retrieved from https://idiyas.com/inventor/xiaodong-chen-3q5o5sni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaodong Chen in Hepatitis B Treatment

Introduction

Xiaodong Chen is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hepatitis B. His innovative work has the potential to impact the lives of many patients suffering from this viral infection.

Latest Patents

Xiaodong Chen holds a patent for a compound containing a fused ring, which is detailed in his patent titled "Compound containing fused ring, use thereof and pharmaceutical composition containing same." This compound has been shown to significantly reduce the levels of HBsAg, HBeAg, and HBV DNA. It can be utilized in the preparation of a drug for treating hepatitis B, showcasing promising market prospects.

Career Highlights

Xiaodong Chen is currently associated with Nanjing Hepo Pharmaceutical Co., Ltd. His work at this company emphasizes his commitment to advancing pharmaceutical research and development. His innovative approach has led to the creation of effective treatments for hepatitis B.

Collaborations

Xiaodong Chen has collaborated with notable colleagues, including Pengfei Qian and Fengbo Li. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Xiaodong Chen's contributions to the field of pharmaceuticals, particularly in hepatitis B treatment, highlight his innovative spirit and dedication to improving healthcare. His patent and ongoing work at Nanjing Hepo Pharmaceutical Co., Ltd. position him as a key figure in the fight against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…